Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID06989580

Clinical Data Collection to Develop Improved Arrhythmia and Heart Failure Management Using BIOMONITOR

Led by Biotronik SE & Co. KG · Updated on 2025-09-08

300

Participants Needed

2

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are studying patients with heart failure (HF) who often experience irregular heartbeats called arrhythmias, including a common type called atrial fibrillation (AF). These arrhythmias can worsen heart failure, increasing the risk of strokes and death. While most knowledge comes from patients with devices like ICDs or CRTs, this study focuses on those who do not qualify for these devices. The goal is to better understand arrhythmias and worsening heart failure (WHF) in this group to help improve care. Participants receive a BIOMONITOR IV device, which is implanted and updated with special study software to collect detailed heart activity data remotely over a long period. The device also tracks fluid levels, breathing rate, and body position to provide more information that may predict WHF events. All participants use this investigational device throughout the study. During approximately 3.5 years of follow-up, researchers will monitor heart failure events confirmed by a committee and track arrhythmias and related treatments. Participants will attend follow-up visits in person and by phone, use a CardioMessenger device, and accept remote monitoring. The collected data will help develop a predictive algorithm for early intervention to reduce hospital visits and deaths related to worsening heart failure.

CONDITIONS

Brief Title

BIO|CONCEPT.BIOMONITOR-HF Collect Clinical Data From Heart Failure Patients Using BIOMONITOR Devices With a Study Specific Research Software

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patient has diagnosed heart failure for at least 90 days with current symptoms compatible with NYHA class II or III
  • Has at least one of the following: a documented hospital admission for worsening heart failure within the last 12 months, or an unscheduled outpatient visit with increased diuretic therapy within the last 6 months, or elevated NT-proBNP/BNP values within the last 3 months
  • Ability to understand the study and provide written informed consent
  • Willingness to attend follow-up visits in person and by phone
  • Ability and willingness to use the CardioMessenger device and accept the BIOTRONIK Home Monitoring system
Not Eligible

You will not qualify if you...

  • Implanted with pacemaker, ICD, CRT device, or implantable cardiac monitor
  • Has a current Class I indication for pacemaker, ICD, or CRT
  • Permanent or long-standing persistent atrial fibrillation
  • Stroke, myocardial infarction, or heart surgery within 3 months prior to enrollment
  • On chronic renal or peritoneal dialysis
  • Has complex adult congenital heart disease
  • Active cancer under chemotherapy, immunotherapy, or radiation
  • Life expectancy less than 1 year
  • Under 18 years of age
  • Participating in another device or drug trial that may interfere with this study or affect outcomes

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Implementation

Duration - 1 day

Participants have a BIOMONITOR IV device inserted, which is then updated with study-specific research software to collect clinical data.

1 visit (in-person)

Long-term Monitoring

Duration - Approximately 3.5 years

Participants are monitored using the BIOMONITOR device and associated home monitoring system to collect data on arrhythmias and heart failure events over the study period.

Regular follow-up visits in person and by phone during the study period

Trial Site Locations

Total: 2 locations

1

Ziekenhuis Oost Limburg AV

Genk, Belgium

Actively Recruiting

2

Peter Osypka Herzzentrum

Munich, Germany

Not Yet Recruiting

Loading map...

Research Team

J

Jan Boergermann, PhD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

DIAGNOSTIC

Number of Arms

1

Similar Trials

Extensive Post-discharge Counselling and Phone-based Follow-...

Heart Failure

Actively Recruiting

1 location

320-detector Computed Tomography to Assess Myocardial Extrac...

Atrial Fibrillation

Actively Recruiting

1 location

Three-Dimensional Assessment of Right Ventricular Function i...

Heart Failure

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here